Intrinsiqs

Is PROCEPT BioRobotics Corporation overvalued?

PROCEPT BioRobotics Corporation (PRCT) — key valuation metrics and fundamentals.

No verdict
Price
$23.80
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$1.37B
Dividend yield
0.0%
Return on equity
-33.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares PRCT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.